The Relationship Between C-Reactive Protein–Triacylglycerol–Glucose Index and All-Cause Mortality in Patients With Cardiovascular Disease: A Retrospective Cohort Study and Development of a Machine Learning Prediction Model
Wenlong Ding, Fachao Shi, Zheng Wang, Long Wang, Caoyang Fang
{"title":"The Relationship Between C-Reactive Protein–Triacylglycerol–Glucose Index and All-Cause Mortality in Patients With Cardiovascular Disease: A Retrospective Cohort Study and Development of a Machine Learning Prediction Model","authors":"Wenlong Ding, Fachao Shi, Zheng Wang, Long Wang, Caoyang Fang","doi":"10.1155/cdr/6914985","DOIUrl":null,"url":null,"abstract":"<p><b>Objective:</b> The CTI is increasingly recognized as a new marker for assessing inflammation and insulin resistance. However, the relationship between CTI and all-cause mortality risk in patients with CVD remains unclear.</p><p><b>Methods:</b> We analyzed data from the NHANES from 1999 to 2010. The correlation between CTI and all-cause mortality risk in CVD patients was examined using Cox regression analysis. Nonlinear relationships between CTI and all-cause mortality risk were explored through restricted cubic splines and Cox proportional hazards regression. We employed six ML models, including RF, LightGBM, DT, XGBoost, LR, and KNN, to predict all-cause mortality risk in CVD patients based on CTI and SHAP for interpretability.</p><p><b>Results:</b> A total of 1429 CVD patients were included, with 849 all-cause deaths recorded during the follow-up period. After adjusting for potential confounding factors, the highest quartile of CTI (Q4) significantly increased the risk of all-cause mortality compared to the lowest quartile (Q1) (HR = 1.38, 95% CI: 1.04–1.84, <i>p</i> = 0.03). Restricted cubic splines demonstrated a nonlinear relationship between CTI and all-cause mortality risk in CVD patients. Among the machine learning models, the LightGBM model exhibited the best predictive performance, with an ROC of 0.967, accuracy of 0.909, sensitivity of 0.906, specificity of 0.914, <i>F</i>1 score of 0.922, recall of 0.906, and PR of 0.979. SHAP analysis identified age, BU, and CTI as the primary predictive factors, with CTI positively correlated with all-cause mortality risk in CVD patients.</p><p><b>Conclusion:</b> There is a nonlinear relationship between CTI and all-cause mortality risk in CVD patients, with elevated CTI levels significantly associated with increased mortality risk. Additionally, for the first time, this study constructed a machine learning model to predict all-cause mortality risk in cardiovascular disease using CTI, with LightGBM demonstrating the best predictive performance. SHAP analysis identified age, BUN, and CTI as critical factors in the prediction, providing valuable references for future related research.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2025 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/6914985","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/6914985","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The CTI is increasingly recognized as a new marker for assessing inflammation and insulin resistance. However, the relationship between CTI and all-cause mortality risk in patients with CVD remains unclear.
Methods: We analyzed data from the NHANES from 1999 to 2010. The correlation between CTI and all-cause mortality risk in CVD patients was examined using Cox regression analysis. Nonlinear relationships between CTI and all-cause mortality risk were explored through restricted cubic splines and Cox proportional hazards regression. We employed six ML models, including RF, LightGBM, DT, XGBoost, LR, and KNN, to predict all-cause mortality risk in CVD patients based on CTI and SHAP for interpretability.
Results: A total of 1429 CVD patients were included, with 849 all-cause deaths recorded during the follow-up period. After adjusting for potential confounding factors, the highest quartile of CTI (Q4) significantly increased the risk of all-cause mortality compared to the lowest quartile (Q1) (HR = 1.38, 95% CI: 1.04–1.84, p = 0.03). Restricted cubic splines demonstrated a nonlinear relationship between CTI and all-cause mortality risk in CVD patients. Among the machine learning models, the LightGBM model exhibited the best predictive performance, with an ROC of 0.967, accuracy of 0.909, sensitivity of 0.906, specificity of 0.914, F1 score of 0.922, recall of 0.906, and PR of 0.979. SHAP analysis identified age, BU, and CTI as the primary predictive factors, with CTI positively correlated with all-cause mortality risk in CVD patients.
Conclusion: There is a nonlinear relationship between CTI and all-cause mortality risk in CVD patients, with elevated CTI levels significantly associated with increased mortality risk. Additionally, for the first time, this study constructed a machine learning model to predict all-cause mortality risk in cardiovascular disease using CTI, with LightGBM demonstrating the best predictive performance. SHAP analysis identified age, BUN, and CTI as critical factors in the prediction, providing valuable references for future related research.
期刊介绍:
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.
Subject areas include (but are by no means limited to):
Acute coronary syndrome
Arrhythmias
Atherosclerosis
Basic cardiac electrophysiology
Cardiac catheterization
Cardiac remodeling
Coagulation and thrombosis
Diabetic cardiovascular disease
Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
Hyperlipidemia
Hypertension
Ischemic heart disease
Vascular biology
Ventricular assist devices
Molecular cardio-biology
Myocardial regeneration
Lipoprotein metabolism
Radial artery access
Percutaneous coronary intervention
Transcatheter aortic and mitral valve replacement.